JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area tgf tgf bcr abl'

Search results for: 'research area tgf tgf bcr abl'

A8232 Nilotinib(AMN-107)

1 Citation

Target: Bcr-Abl

Summary: Bcr-Abl kinase inhibitor,selective

≥26.5 mg/mL
A8604 GNF 5

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor
A8603 GNF 2

Summary: Bcr-Abl inhibitor

insoluble in H2O; ≥18.7 mg/mL
A3754 RepSox

Summary: ALK5 inhibitor,potent and selective

insoluble in H2O; ≥14.35 mg/mL
A3017 Dasatinib (BMS-354825)

4 Citation

Summary: Src and BCR-Abl inhibitor

≥24.4 mg/mL
A8249 SB 431542

2 Citation

Summary: ALK inhibitor
A5467 Ponatinib (AP24534)

1 Citation

Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src

Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor

≥53.3 mg/mL
A1670 Enzastaurin (LY317615)

2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
A8330 CX-4945 (Silmitasertib)

9 Citation

Summary: CK2 inhibitor

≥103.5 mg/mL
A8342 GF 109203X

1 Citation

Target: PKC

Summary: Protein kinase C,MLCK,PKG and PKA inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL